Supplier to the pharma, biotech and specialty ingredients markets, Lonza, has expanded its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in the US.
Accord Healthcare, a generic pharmaceutical company, has opened a new facility in Fawdon, Newcastle, expanding its portfolio to four sites situated within the UK.
Global innovator and provider of cold chain packaging systems for the pharma industry, Softbox, has acquired TP3 Global, which manufactures the ‘SilverSkin’ brand.
The collaboration between AstraZeneca and TissUse is progressing with the establishment of relevant microphysiological system (MPS) models based on TissUse’s multi-organ-chip technology, the companies announced.
Anton Paar understands your need for completely traceable results and supports you with a qualification and validation package following the 4Q model which fulfills the requirements of the pharmaceutical industry
Micro filtration and single-use system specialist, Meissner Filtration Products, has acquired a supplier of advanced aseptic filling systems and sealers to the pharmaceutical industry, PDC Aseptic Filling Systems.
Full-service contract manufacturer of biopharmaceutical proteins, Wacker Biotech, has obtained US Food and Drug Administration (FDA) approval to manufacture reteplase — the active ingredient in the drug Retavase.
The US Food and Drug Administration (FDA) has granted fast track designation to Infirst Healthcare’s haemoglobin spray, Granulox, for the treatment of diabetic foot ulcers (DFUs).
Researchers from the University of Aberdeen have shown that a drug being trialled for the treatment of breast cancer and diabetes is capable of ‘melting away’ the fat build up inside arteries that can cause heart attacks and strokes.
